Intratumoral injection of the seasonal flu shot converts immunologically cold tumors to hot and serves as an immunotherapy for cancer.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
14 01 2020
Historique:
pubmed: 1 1 2020
medline: 16 4 2020
entrez: 1 1 2020
Statut: ppublish

Résumé

Reprogramming the tumor microenvironment to increase immune-mediated responses is currently of intense interest. Patients with immune-infiltrated "hot" tumors demonstrate higher treatment response rates and improved survival. However, only the minority of tumors are hot, and a limited proportion of patients benefit from immunotherapies. Innovative approaches that make tumors hot can have immediate impact particularly if they repurpose drugs with additional cancer-unrelated benefits. The seasonal influenza vaccine is recommended for all persons over 6 mo without prohibitive contraindications, including most cancer patients. Here, we report that unadjuvanted seasonal influenza vaccination via intratumoral, but not intramuscular, injection converts "cold" tumors to hot, generates systemic CD8

Identifiants

pubmed: 31888983
pii: 1904022116
doi: 10.1073/pnas.1904022116
pmc: PMC6969546
doi:

Substances chimiques

Adjuvants, Immunologic 0
Basic-Leucine Zipper Transcription Factors 0
Influenza Vaccines 0
Repressor Proteins 0
SNFT protein, mouse 0
Interleukin-10 130068-27-8
Squalene 7QWM220FJH

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1119-1128

Subventions

Organisme : NIGMS NIH HHS
ID : R25 GM055145
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA225830
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM008339
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA072720
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA225993
Pays : United States

Informations de copyright

Copyright © 2020 the Author(s). Published by PNAS.

Déclaration de conflit d'intérêts

Competing interest statement: P.K.B. and H.L.K. are employees of Replimune, Inc. E.A.S. receives research funding from Astellas/Medivation. M.J.F receives research funding from Pfizer and Biodesix, consulting funds from Astrazeneca and Pfizer, and honoraria from AstraZeneca, Merck, and Genentech. All other authors declare no conflicts of interest.

Références

J Clin Invest. 2017 Aug 1;127(8):2930-2940
pubmed: 28650338
Trends Cancer. 2016 Dec;2(12):747-757
pubmed: 28626801
Curr Pharmacol Rep. 2017;3(6):315-320
pubmed: 29201631
J Immunol. 2005 May 15;174(10):6477-89
pubmed: 15879151
Nature. 2014 Nov 27;515(7528):568-71
pubmed: 25428505
Cancer Res. 2012 Apr 1;72(7):1642-50
pubmed: 22311675
Science. 2018 Oct 12;362(6411):
pubmed: 30309915
Vaccine. 2012 Jun 19;30(29):4341-8
pubmed: 22682289
Clin Cancer Res. 2015 Nov 15;21(22):5047-56
pubmed: 26567364
JAMA Oncol. 2019 Jul 25;:null
pubmed: 31343665
Sci Rep. 2016 Jan 21;6:19570
pubmed: 26791076
Proc Natl Acad Sci U S A. 2017 Jan 24;114(4):740-745
pubmed: 28069963
Trends Mol Med. 2016 Jun;22(6):448-451
pubmed: 27174038
Nature. 2018 May;557(7706):575-579
pubmed: 29769722
Cancer Immunol Res. 2014 Mar;2(3):263-73
pubmed: 24778322
Elife. 2018 Sep 04;7:
pubmed: 30179157
N Engl J Med. 2014 Dec 4;371(23):2189-2199
pubmed: 25409260
Proc Natl Acad Sci U S A. 2001 Dec 18;98(26):15155-60
pubmed: 11724950
Nat Med. 2019 May;25(5):814-824
pubmed: 30962585
PLoS One. 2013 Nov 06;8(11):e79194
pubmed: 24223176
Immunol Rev. 2017 Mar;276(1):5-8
pubmed: 28258698
Adv Exp Med Biol. 2017;1036:19-31
pubmed: 29275462
J Clin Invest. 2017 Mar 1;127(3):772-779
pubmed: 28248202
Infect Chemother. 2013 Jun;45(2):159-74
pubmed: 24265964
J Immunol. 2017 Apr 1;198(7):2979-2988
pubmed: 28202614
Cell Rep. 2016 Oct 18;17(4):957-965
pubmed: 27760326
Adv Immunol. 2006;90:215-41
pubmed: 16730265
J Virol. 2014 Feb;88(3):1636-51
pubmed: 24257598
Immunity. 2015 Apr 21;42(4):607-12
pubmed: 25902480
Clin Cancer Res. 2018 Jan 1;24(1):62-72
pubmed: 29061643
Front Immunol. 2018 Jun 01;9:1082
pubmed: 29910800
PLoS One. 2017 Jan 3;12(1):e0169344
pubmed: 28046080
Immunology. 2013 Feb;138(2):105-15
pubmed: 23216602
Sci Immunol. 2017 May 19;2(11):null
pubmed: 28763795
Science. 2008 Nov 14;322(5904):1097-100
pubmed: 19008445
Nat Med. 2018 May;24(5):541-550
pubmed: 29686425
Nat Commun. 2019 Feb 4;10(1):567
pubmed: 30718505
Front Pharmacol. 2017 Aug 23;8:561
pubmed: 28878676
Cancer Immunol Immunother. 1990;32(2):117-24
pubmed: 2289203
Cancer Detect Prev. 2006;30(1):83-93
pubmed: 16490323
PLoS Pathog. 2012;8(3):e1002572
pubmed: 22412374
Regul Toxicol Pharmacol. 2016 Nov;81:113-119
pubmed: 27498239
Nat Rev Drug Discov. 2019 Mar;18(3):197-218
pubmed: 30610226
Sci Transl Med. 2011 Jun 1;3(85):85ra48
pubmed: 21632986
J Immunother. 2002 May-Jun;25(3):218-25
pubmed: 12000863
Cancer Res. 2015 Jan 1;75(1):5-10
pubmed: 25524899
Blood. 2010 Jul 29;116(4):564-74
pubmed: 20424184
J Immunol. 2006 Sep 1;177(5):2917-25
pubmed: 16920927
J Immunother Cancer. 2018 Aug 6;6(1):78
pubmed: 30081947
J Exp Med. 2010 Aug 2;207(8):1791-804
pubmed: 20660615
Nature. 1959 Jul 25;184(Suppl 5):291-2
pubmed: 14428599
Proc R Soc Med. 1910;3(Surg Sect):1-48
pubmed: 19974799
Nat Rev Drug Discov. 2015 Sep;14(9):642-62
pubmed: 26323545
Influenza Other Respir Viruses. 2008 Sep;2(5):147-54
pubmed: 19453419
PLoS One. 2018 Feb 6;13(2):e0191896
pubmed: 29408882
Oncoimmunology. 2012 Jul 1;1(4):409-418
pubmed: 22754759
J Clin Oncol. 2004 Mar 15;22(6):1136-51
pubmed: 15020616
J Immunother Cancer. 2018 Jan 08;6(1):3
pubmed: 29307306

Auteurs

Jenna H Newman (JH)

Rutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, NJ 08901.

C Brent Chesson (CB)

Rutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, NJ 08901.

Nora L Herzog (NL)

Rutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, NJ 08901.

Praveen K Bommareddy (PK)

Rutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, NJ 08901.

Salvatore M Aspromonte (SM)

Rutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, NJ 08901.

Russell Pepe (R)

Rutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, NJ 08901.
Department of Surgery, Rutgers Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, New Brunswick, NJ 08901.

Ricardo Estupinian (R)

Rutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, NJ 08901.
Department of Internal Medicine, Section of Hematology, Oncology, and Cell Therapy, Rush University Medical Center, Chicago, IL 60612.

Mones M Aboelatta (MM)

Rutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, NJ 08901.
Institute for Genomic Medicine, Columbia University Irving Medical Center, New York, NY 10032.

Stuti Buddhadev (S)

Rutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, NJ 08901.

Saeed Tarabichi (S)

Department of Surgery, Rutgers Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, New Brunswick, NJ 08901.

Michael Lee (M)

Department of Surgery, Rutgers Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, New Brunswick, NJ 08901.

Shengguo Li (S)

Rutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, NJ 08901.

Daniel J Medina (DJ)

Rutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, NJ 08901.

Eileena F Giurini (EF)

Department of Internal Medicine, Section of Hematology, Oncology, and Cell Therapy, Rush University Medical Center, Chicago, IL 60612.

Kajal H Gupta (KH)

Department of Internal Medicine, Section of Hematology, Oncology, and Cell Therapy, Rush University Medical Center, Chicago, IL 60612.

Gabriel Guevara-Aleman (G)

Department of Internal Medicine, Section of Hematology, Oncology, and Cell Therapy, Rush University Medical Center, Chicago, IL 60612.

Marco Rossi (M)

Department of Internal Medicine, Section of Hematology, Oncology, and Cell Therapy, Rush University Medical Center, Chicago, IL 60612.

Christina Nowicki (C)

Department of Internal Medicine, Section of Hematology, Oncology, and Cell Therapy, Rush University Medical Center, Chicago, IL 60612.

Abdulkareem Abed (A)

Department of Internal Medicine, Section of Hematology, Oncology, and Cell Therapy, Rush University Medical Center, Chicago, IL 60612.

Josef W Goldufsky (JW)

Department of Internal Medicine, Section of Hematology, Oncology, and Cell Therapy, Rush University Medical Center, Chicago, IL 60612.

Joseph R Broucek (JR)

Department of Internal Medicine, Section of Hematology, Oncology, and Cell Therapy, Rush University Medical Center, Chicago, IL 60612.
Department of Surgery, Vanderbilt University Medical Center, Nashville, TN 37232.

Raquel E Redondo (RE)

Department of Internal Medicine, Section of Hematology, Oncology, and Cell Therapy, Rush University Medical Center, Chicago, IL 60612.
Department of Surgery, Franciscan Health, Munster, IN 46321.

David Rotter (D)

Rutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, NJ 08901.

Sachin R Jhawar (SR)

Rutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, NJ 08901.
Department of Radiation Oncology, Arthur G. James Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210.

Shang-Jui Wang (SJ)

Rutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, NJ 08901.

Frederick J Kohlhapp (FJ)

Rutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, NJ 08901.

Howard L Kaufman (HL)

Division of Surgical Oncology, Massachusetts General Hospital, Boston, MA 02114.
Replimune, Inc., Woburn, MA 01801.

Paul G Thomas (PG)

Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105.
Integrated Biomedical Sciences Program, University of Tennessee Health Science Center, Memphis, TN 38105.

Vineet Gupta (V)

Department of Internal Medicine, Section of Hematology, Oncology, and Cell Therapy, Rush University Medical Center, Chicago, IL 60612.

Timothy M Kuzel (TM)

Department of Internal Medicine, Section of Hematology, Oncology, and Cell Therapy, Rush University Medical Center, Chicago, IL 60612.

Jochen Reiser (J)

Department of Internal Medicine, Section of Hematology, Oncology, and Cell Therapy, Rush University Medical Center, Chicago, IL 60612.

Joyce Paras (J)

Rutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, NJ 08901.

Michael P Kane (MP)

Rutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, NJ 08901.

Eric A Singer (EA)

Rutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, NJ 08901.
Department of Surgery, Rutgers Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, New Brunswick, NJ 08901.

Jyoti Malhotra (J)

Rutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, NJ 08901.

Lisa K Denzin (LK)

Child Health Institute of New Jersey, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ 08901.

Derek B Sant'Angelo (DB)

Child Health Institute of New Jersey, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ 08901.

Arnold B Rabson (AB)

Child Health Institute of New Jersey, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ 08901.

Leonard Y Lee (LY)

Department of Surgery, Rutgers Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, New Brunswick, NJ 08901.

Ahmed Lasfar (A)

Rutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, NJ 08901.
Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ 08854.

John Langenfeld (J)

Department of Surgery, Rutgers Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, New Brunswick, NJ 08901.

Jason M Schenkel (JM)

Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139.
Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115.

Mary Jo Fidler (MJ)

Department of Internal Medicine, Section of Hematology, Oncology, and Cell Therapy, Rush University Medical Center, Chicago, IL 60612.

Emily S Ruiz (ES)

Department of Dermatology, Brigham and Women's Hospital, Boston, MA 02130.
Harvard Medical School, Boston, MA 02115.

Amanda L Marzo (AL)

Department of Internal Medicine, Section of Hematology, Oncology, and Cell Therapy, Rush University Medical Center, Chicago, IL 60612.

Jai S Rudra (JS)

Department of Biomedical Engineering, McKelvey School of Engineering, Washington University in Saint Louis, Saint Louis, MO 63105.

Ann W Silk (AW)

Harvard Medical School, Boston, MA 02115.
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215.

Andrew Zloza (A)

Rutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, NJ 08901; Andrew_Zloza@rush.edu.
Department of Surgery, Rutgers Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, New Brunswick, NJ 08901.
Department of Internal Medicine, Section of Hematology, Oncology, and Cell Therapy, Rush University Medical Center, Chicago, IL 60612.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH